ʻO ka weheweheʻana
ʻO nā Allitinib indea 2-Acetyll-4-Mithylpyridinene Hōʻikeʻiaʻo ka waena ma waena o ka noiʻi a me ka hoʻomohalaʻana i nā noi aʻo e hana nei, e hana ana i kahiʻano kiko'ī.
ʻO kā mākou Almedibic Internagend 2-Acetyll-4-Mithylpyridine kahi kūpono a me ke kaumaha a me ka loaʻaʻana o nā kūlana kiʻekiʻe a me nā kiʻekiʻe kiʻekiʻe. Ke haʻaheo nei mākou iā mākou iho i ka hōʻoiaʻana i nā huahana kiʻekiʻe loa o nā huahana kiʻekiʻe loa a hoʻokō i nā koi koʻikoʻi o kaʻoihana lāʻau lapaʻau. ʻO kā mākou kūpaʻa i nā mea maikaʻi e hōʻoia i ka loaʻaʻana o kā mākou mea kūʻai aku i nā mea kūʻai aku maikaʻi loa e hālāwai me kā lākou noiʻi a me nā pono hana hana.
Koho iā mākou
ʻO Jdk i nā hale hana mua o nā papa mua a me nā mea hoʻokele waiwai kūpono, e hōʻoia ana i ka nui o ka pono o ka API i kauʻia. ʻO ka hui loea e hoʻopiʻi iā R & D o ka huahana. E kū'ē iā lāua, keʻimi nei mākou no CMM & CDMO ma ka hale kūʻai home a me ka mākeke honua.